Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
Cardiovascular (CV) diseases are a serious concern in rheumatoid arthritis (RA), accounting for approximately one-third to one-half of all RA-related deaths. Besides the attempts to identify new risk factors, the proper management of traditional CV risk factors such as dyslipidemia should become a p...
Main Authors: | Calin D. Popa, Elke Arts, Jaap Fransen, Piet L. C. M. van Riel |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/785946 |
Similar Items
-
Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process.
by: Jae-Yong Kim, et al.
Published: (2016-01-01) -
Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis.
by: Jaap Fransen, et al.
Published: (2016-01-01) -
High-density lipoprotein cholesterol, apolipoprotein E and atherogenic index of plasma are associated with risk of chronic kidney disease
by: Jasmina Smajić, et al.
Published: (2018-08-01) -
Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls
by: Liao, Katherine P., et al.
Published: (2014) -
Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography
by: Milada Dobiášová, et al.
Published: (2011-03-01)